INVESTOR RELATIONS

LATEST NEWS
events
FINANCIAL RESULTS
CORPORATE ppt

SCINAI IMMUNOTHERAPEUTICS
(NASDAQ: SCNI)

COMPANY OVERVIEW

Scinai is a biopharmaceutical company focused on developing inflammation and immunology (I&I) biological products and on providing CDMO services through its Scinai Bio-services business unit.

With over 20 years of experience in recombinant protein process development and cGMP manufacturing, Scinai is on a mission to elevate drug development. Every step of the way.

Management
Board of Directors
Scientific Advisory Board
vIEW OUR Corporate presentation

Our Business Units

Scinai operates with two complementing Business Units: R&D and CDMO Bioservices.

CONTACT US

Latest News

EVENTS

Sign up for news and updates

Sign up with your email address.

FINANCIAL & BUSINESS UPDATEs

LATEST UPDATES

SEC

ANNUAL REPORTS 2024

QUARTERLY REPORTS

Governance

Code of Conduct
Audit Committee Charter
Compensation Committee Charter

Contact us